Myovant Sciences (MYOV) Financials

$26.98

$-0.01 (-0.04%)

As on 09-Mar-2023 16:01EDT

Market cap

$2,624 Mln

Revenue (TTM)

$379 Mln

P/E Ratio

--

P/B Ratio

70

Div. Yield

0 %

Annual
Quarterly

Cashflow ($ Mln)	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13
Cash From Operating Activities	--	-268.56	370.63	-221.17	-224.09	-117.26
Cash Flow from Investing Activities	--	-18.02	-9.21	-3.94	-1.24	-0.60
Cash from Financing Activities	--	25.91	238.05	145.93	273.90	45.65
Net Cash Inflow / Outflow	--	-260.68	599.46	-79.18	48.58	-72.21

Financials Ratios	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13
Adjusted EPS ($)	-1.93	-2.21	-2.83	-3.36	-4.08	-2.39
Cash EPS ($)	--	-2.18	-2.81	-3.34	-4.08	-2.38
Adjusted Book Value ($)	--	--	--	--	0.06	0.63
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-2.89	4.12	-2.57	-3.34	-1.95
Free Cash Flow per Share ($)	--	-2.90	4.10	-2.58	-3.36	-1.96

Profitability Ratios	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13
ROCE (%)	--	458.46	-1,515.68	-475.11	-295.62	-115.47
ROE (%)	--	49.79	110.39	556.05	-1,300.67	-140.10
ROA (%)	-24.14	-33.09	-61.41	-207.23	-187.31	-94.13
EBIT Margin (%)	-37.90	-80.95	-412.02	--	-29,994.78	--
Net Margin (%)	-48.06	-89.03	-337.02	42,623.75	-31,050.06	--
Cash Profit Margin (%)	0.00	--	--	--	--	--

Growth Ratios	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13
Revenue Growth (%)	91.46	2.89	--	-1.00	--	--
EBIT Growth (%)	32.25	23.50	11.31	-4.28	-87.42	-68.83
Net Profit Growth (%)	19.42	19.27	11.71	-5.64	-90.95	-71.69
EPS Growth (%)	22.51	0.22	0.16	0.18	-0.71	-0.40
Book Value Growth (%)	-23.79	--	--	--	--	--

Valuation Ratios	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13
Price / Earnings	--	-6.01	-7.26	-2.25	-5.85	-8.91
Price / Book Value	70.01	-2.62	-5.23	-6.00	369.01	33.83
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-17.34	-6.38	-6.35	-2.54	-5.85	-8.61
Close Price ($)	26.96	13.32	20.58	7.55	23.87	21.27
High Price ($)	27.03	27.43	30.90	26.02	27.45	24.14
Low Price ($)	7.67	11.30	7.17	4.14	14.32	9.92
Market Cap ($ Cr)	2,624.06	--	--	--	--	--

Solvency Ratios	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13
Debt to Equity	-0.64	-0.78	-1.04	-1.17	22.93	1.16
Short term debt to equity ratio	0.00	0.00	-0.01	-0.01	1.42	1.16
Current Ratio	1.57	1.95	2.50	1.02	2.32	3.09
Quick Ratio	1.45	1.92	2.50	--	--	3.09
Interest Coverage	-7.71	-13.38	-23.50	-21.76	-29.96	-68.91

Operating Efficiency Ratios	TTM	Mar-22	Mar-21	Mar-20	Mar-19	Mar-18	Mar-17	Mar-16	Mar-15	Mar-14	Mar-13
Debtors to sales (%)	11.61	10.34	6.02	--	59.48	--
Asset Turnover	0.50	0.37	0.14	--	0.01	--
Receivable days	--	21.70	21.98	--	315.91	--
Inventory Days	--	36.12	485.33	--	--	--
Payable days	--	106.49	3,080.28	--	322.91	705.78
Cash Conversion Cycle	--	-48.67	-2,572.97	--	-7.00	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.